The Flowr Corporation (TSXV:FLWR) was featured in an article by Cantech Letter that discussed the company’s recent coverage by Clarus Securities. Within the Clarus report, analyst Noel Atkinson gave Flowr a speculative buy rating and one year price target of $5. He also highlighted some of the advantages that would make the company appealing to investors.
According to Atkinson, Flowr is one of a few Canadian licensed producers to successfully scale indoor cultivation of premium cannabis, which will allow them to meet consumer demands for premium cannabis. He also touched on the company’s experienced founding production team who have decades of collective experience in designing, building and optimizing indoor cultivation projects and are known for their success with Medreleaf’s facility in Markham, Ontario, which is still considered to be the gold standard for indoor cultivation in Canada. Additionally, he also highlighted the supply agreements Flowr has with three provinces, including British Columbia and Ontario, and that they will be ramping up their revenues as the expansions underway at the company’s Kelowna campus go online.
To view the full article, click here.